MRI finds different brain loss in MS and look-alikes

Credibility

Interest

Share:1 min read

Key Takeaway

MRI scans found different patterns of brain and upper spinal cord shrinkage in MS and two conditions often mistaken for MS.

What They Found

Over time, people with one MS look-alike lost brain volume faster than healthy volunteers. At the first scan, several brain areas were less shrunken in this group than in people with MS. Over time, this group had less upper spinal cord shrinkage than people with MS or the other look-alike. A fluid-filled space in the brain grew more in this group than in either comparison group. Within this group, some brain and spinal cord measurements were linked to disability scores.

Who Should Care and Why

The study included people with MS, people with two conditions often mistaken for MS, and healthy volunteers. It compared how brain and upper spinal cord measurements changed over time. The findings show that these conditions did not follow the same pattern of shrinkage. In one look-alike condition, brain and spinal cord measurements were linked to disability. The study did not identify which forms of MS the participants had.

Important Considerations

You should know this was a comparison of MRI scans, not a treatment test. The study included 293 people, including 160 with MS. You cannot tell from these findings whether shrinkage caused disability.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News